Forty Seven (Forty Seven) Forward Dividend Yield % : 0.00% (As of May. 22, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Forty Seven Forward Dividend Yield %?

As of today (2024-05-22), the Forward Annual Dividend Yield of Forty Seven is 0.00%.

As of today (2024-05-22), the Trailing Annual Dividend Yield of Forty Seven is 0.00%.

FTSV's Forward Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.55
* Ranked among companies with meaningful Forward Dividend Yield % only.

Forty Seven's Dividends per Share for the three months ended in Dec. 2019 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Forty Seven's Forward Dividend Yield %

For the Biotechnology subindustry, Forty Seven's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Forty Seven's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Forty Seven's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Forty Seven's Forward Dividend Yield % falls into.

Forty Seven Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Forty Seven (NAS:FTSV) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Forty Seven Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Forty Seven's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Forty Seven (Forty Seven) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Forty Seven Inc (NAS:FTSV) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1490 Oâ€™Brien Drive, Suite A, Menlo Park, CA, USA, 94025

Website

https://www.fortyseveninc.com

Forty Seven Inc is a clinical-stage immuno-oncology company. It is engaged in developing novel checkpoint therapies to activate macrophages and help the patients in their fight against cancer. It founded that blocking CD47, a key signaling molecule that is overexpressed on cancer cells renders tumors susceptible to macrophages. It is also preparing investigational compounds into clinical testing. FSI-174, an anti-cKIT antibody, is being developed in combination with magrolimab as a novel, all-antibody conditioning regimen to address the limitations of current stem cell transplantation conditioning regimens. FSI-189, an anti-SIRP-alpha antibody, is being developed for the treatment of cancer, and certain non-oncology conditions, including transplantation conditioning.

Executives

Dennis Henner	director	THE JOHN HANCOCK TOWER, 200 CLARENDON STREET, 54TH FLOOR, BOSTON MA 02116
Kristine M Ball	director	C/O RELYPSA, INC., 700 SAGINAW DRIVE, REDWOOD CITY CA 94063
Ann D Rhoads	officer: Chief Financial Officer	4000 NORTH FIRST STREET, SAN JOSE CA 95134
Ian T Clark	director	SOLAZYME, INC., 225 GATEWAY BLVD., SOUTH SAN FRANCISCO CA 94080
Jeffrey W Bird	director	755 PAGE MILL RD STE A-200, PALO ALTO CA 94304-1005
Lightspeed General Partner X, L.p.	10 percent owner	2200 SAND HILL ROAD, MENLO PARK CA 94025
Lightspeed Ultimate General Partner X, Ltd.	10 percent owner	2200 SAND HILL ROAD, MENLO PARK CA 94025
Jeremy Liew	10 percent owner	2200 SAND HILL ROAD, MENLO PARK CA 94025
Lightspeed Venture Partners X, L.p.	10 percent owner	2200 SAND HILL ROAD, MENLO PARK CA 94025
Barry Eggers	10 percent owner	2200 SAND HILL ROAD, MENLO PARK CA 94025
Peter Nieh	10 percent owner	2200 SAND HILL ROAD, MENLO PARK CA 94025
Ravi Mhatre	10 percent owner	2200 SAND HILL ROAD, MENLO PARK CA 94025
Stephen A Schwarzman	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Clarus Iii L.l.c.	10 percent owner	C/O THE BLACKSTONE GROUP L.P., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Inc.	10 percent owner	345 PARK AVENUE, NEW YORK NY 10154